emtricitabine and tenofovir disoproxil fumarate
Generic: emtricitabine and tenofovir disoproxil fumarate
Labeler: amneal pharmaceuticals ny llcDrug Facts
Product Profile
Brand Name
emtricitabine and tenofovir disoproxil fumarate
Generic Name
emtricitabine and tenofovir disoproxil fumarate
Labeler
amneal pharmaceuticals ny llc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
emtricitabine 133 mg/1, tenofovir disoproxil fumarate 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69238-2093
Product ID
69238-2093_e3f72707-b2b3-49e4-8b28-a9311e1358cf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209721
Listing Expiration
2026-12-31
Marketing Start
2018-08-26
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
692382093
Hyphenated Format
69238-2093
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
emtricitabine and tenofovir disoproxil fumarate (source: ndc)
Generic Name
emtricitabine and tenofovir disoproxil fumarate (source: ndc)
Application Number
ANDA209721 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 133 mg/1
- 200 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (69238-2093-3)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "e3f72707-b2b3-49e4-8b28-a9311e1358cf", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "upc": ["0369238209433", "0369238209532", "0369238209235", "0369238209334"], "unii": ["OTT9J7900I", "G70B4ETF4S"], "rxcui": ["476556", "1744001", "1744005", "1744009"], "spl_set_id": ["b0459301-2bff-4336-9172-b90c7a582433"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (69238-2093-3)", "package_ndc": "69238-2093-3", "marketing_start_date": "20180826"}], "brand_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "product_id": "69238-2093_e3f72707-b2b3-49e4-8b28-a9311e1358cf", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "69238-2093", "generic_name": "Emtricitabine and Tenofovir Disoproxil Fumarate", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "133 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "200 mg/1"}], "application_number": "ANDA209721", "marketing_category": "ANDA", "marketing_start_date": "20180826", "listing_expiration_date": "20261231"}